Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS)
- Previous Close
27.45 - Open
27.25 - Bid 27.66 x --
- Ask 27.68 x --
- Day's Range
27.17 - 27.80 - 52 Week Range
24.61 - 35.71 - Volume
1,547,930 - Avg. Volume
1,646,543 - Market Cap (intraday)
11.519B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
19.62 - EPS (TTM)
1.41 - Earnings Date --
- Forward Dividend & Yield 1.00 (3.64%)
- Ex-Dividend Date May 26, 2023
- 1y Target Est
40.00
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.
www.cdbio.cnRelated News
Performance Overview: 688739.SS
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688739.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688739.SS
Valuation Measures
Market Cap
11.43B
Enterprise Value
5.87B
Trailing P/E
19.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.40
Price/Book (mrq)
1.18
Enterprise Value/Revenue
3.28
Enterprise Value/EBITDA
8.41
Financial Highlights
Profitability and Income Statement
Profit Margin
26.77%
Return on Assets (ttm)
--
Return on Equity (ttm)
4.85%
Revenue (ttm)
1.75B
Net Income Avi to Common (ttm)
468.45M
Diluted EPS (ttm)
1.41
Balance Sheet and Cash Flow
Total Cash (mrq)
5.59B
Total Debt/Equity (mrq)
0.23%
Levered Free Cash Flow (ttm)
--
Research Analysis: 688739.SS
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 688739.SS
688739.SS does not have Company Insights